Fibrosis in the kidney: is a problem shared a problem halved? - Wikidata - awgldk - TriplyDB

Fibrosis in the kidney: is a problem shared a problem halved?

Fibrosis in the kidney: is a problem shared a problem halved?

http://www.wikidata.org/entity/Q36012555

about

Animal Models to Study Links between Cardiovascular Disease and Renal Failure and Their Relevance to Human Pathology Shear wave elastography in chronic kidney disease: a pilot experience in native kidneys Increasing cGMP-dependent protein kinase activity attenuates unilateral ureteral obstruction-induced renal fibrosis.Tyrosine kinases inhibition by Imatinib slows progression in chronic anti-thy1 glomerulosclerosis of the rat M2 macrophage polarization modulates epithelial-mesenchymal transition in cisplatin-induced tubulointerstitial fibrosis Involvement of NF-κBIZ and related cytokines in age-associated renal fibrosis.Chinese herbal medicine Shenqi Detoxification Granule inhibits fibrosis in adenine induced chronic renal failure rats.Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype - Role of Risk Factors and Epigenetics.Antifibrotic therapy: is an antioxidative regimen the answer?IL-17 Receptor Signaling Negatively Regulates the Development of Tubulointerstitial Fibrosis in the Kidney

P2860

Q26781300-051AE566-8660-443E-96DA-2562C4BE8797 Q30405608-B71D9E18-F6C9-4FDA-83AC-AB404CB78022 Q33568894-E9703B9A-FFD7-4B4A-8BBE-C6030DB246E8 Q35015952-3E8159D1-E647-4AE1-BB25-02666D528526 Q36576981-22184475-8545-46F3-AA83-BA1A67936E4D Q37702513-1C2ED193-C7CC-41C8-94C7-BAD549209151 Q38312509-474BC21F-6B9F-45BB-B084-E9925F013D29 Q41333737-0CF7ADF7-10A4-4BE9-B2D9-FD0EC657F5FA Q42778035-BB6CDF10-A323-4EB1-AFD2-B077E2F79619 Q58567854-A7391D3A-1809-4726-9A1E-2786D763AFAD

P2860

Fibrosis in the kidney: is a problem shared a problem halved?

http://www.wikidata.org/entity/Q36012555

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Fibrosis in the kidney: is a problem shared a problem halved?

@ast

Fibrosis in the kidney: is a problem shared a problem halved?

@en

type

label

Fibrosis in the kidney: is a problem shared a problem halved?

@ast

Fibrosis in the kidney: is a problem shared a problem halved?

@en

prefLabel

Fibrosis in the kidney: is a problem shared a problem halved?

@ast

Fibrosis in the kidney: is a problem shared a problem halved?

@en

P1433

Q36012555-642BDEB1-751C-4094-A57D-2CE0B1D06F88

P1476

Q36012555-16F5353E-C8A6-437F-9D3B-383C1510ADA2

P2093

Q36012555-88149974-D2C3-4082-8E7A-E273CDCCD7DD

P2860

Q36012555-091115AC-A52E-487A-BCE1-B86D6EB5E606

Q36012555-0AE31CE5-ABA6-4E05-93DF-8189CF33E53F

Q36012555-2FB19716-4D85-428F-BDCA-1B0E47616225

Q36012555-31C25B81-B99D-4A32-9069-40B1F88ECA32

Q36012555-42E1245D-837E-4AE0-B6A1-2E0740799A0F

Q36012555-4C11CD46-E34E-4E4A-A90D-76E8590F2817

Q36012555-5C0CA755-EFD3-4DBA-9D23-C8561A378FD5

Q36012555-6A525F1D-8A04-4D8C-A918-E60569FBD79F

Q36012555-7600552C-35C3-41D9-A799-9C92A3012736

Q36012555-7E1C64F3-CF18-4BB9-BC5B-A2A1DC1205BF

P2888

Q36012555-889F3867-E62A-446F-98BC-1BD1BF75ABC9

P304

Q36012555-94C0ED11-E306-440C-A736-0EBFC42D41F2

P31

Q36012555-5892D7BC-2494-4DFE-BF66-00F97364C106

P356

Q36012555-C53464E1-D76A-4EC9-B33A-E51A6F17645C

P433

Q36012555-C76A5577-EE56-469F-9D64-F03F740ED8E9

P478

Q36012555-DCD6A06C-016B-4607-92A3-74B0178D5E66

P50

Q36012555-71AA3F67-656D-4B8F-BF57-6D56235F8DED

P577

Q36012555-12FC9720-6A8D-4BF8-9FBC-1854DBC4DE88

P6179

Q36012555-7F61F0D3-EFA2-44B7-9078-4947A5C7B643

P698

Q36012555-58D6AA62-C85B-4AA9-821C-FCE021AA36CB

P932

Q36012555-7C8F6C3D-4FD9-4A7B-8113-5E5C99A61BC8

P356

1755-1536-5-S1-S14

P1433

Fibrogenesis and Tissue Repair

P1476

Fibrosis in the kidney: is a problem shared a problem halved?

@en

P2093

Tim D Hewitson

http://www.w3.org/2001/XMLSchema#string

P2860

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.

Uremic toxins: new aspects.

Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis

Methylation determines fibroblast activation and fibrogenesis in the kidney.

Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.

Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.

Progression in chronic kidney disease.

Renal fibrosis: new insights into the pathogenesis and therapeutics.

Renin-angiotensin-aldosterone system and progression of renal disease.

P2888

1755-1536-5-s1-s14

P304

S14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1755-1536-5-S1-S14

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1053591961

http://www.w3.org/2001/XMLSchema#string

P698

23259697

http://www.w3.org/2001/XMLSchema#string

P932

3368763

http://www.w3.org/2001/XMLSchema#string